REBECCA RUBIN: Open Payments
NPI 1760192850 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,843 in 82 payments from 11 companies in 2025. Trend: 2023 $1,679 · 2024 $2,727 · 2025 $1,843
Food & beverage: $1,843
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $690 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $423 |
| Janssen Biotech, Inc. | 10 | $174 |
| Janssen Scientific Affairs, LLC | 2 | $159 |
| Mirum Pharmaceuticals, Inc. | 1 | $129 |
| PFIZER INC. | 6 | $107 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Biocon Biologics Inc | 2 | $35 |
| Lilly USA, LLC | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
Products named: ENTYVIO, TREMFYA, LINZESS, RINVOQ, SKYRIZI, Livmarli, CREON, XELJANZ.
Industry payments across LA — which companies pay providers there.
